Skip to main content
SpringerLink
Log in

Anti-inflammatories/antineoplastics

Immune-related myositis and lack of efficacy: 20 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Weill A, et al. Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: A national multicentre study. Rheumatology 60: 5753-5764, No. 12, Dec 2021. Available from: URL: http://rheumatology.oxfordjournals.org/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-inflammatories/antineoplastics. Reactions Weekly 1900, 34 (2022). https://doi.org/10.1007/s40278-022-12386-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-12386-6

Search

Navigation